Obermatt

BioPharma Credit

LSE:BPCR · GB00BDGKMY29
Capital MarketsSmall

360° View

no current rank
Price/Sales55
Price/Earnings55
Price/Book66
Dividend Yield1
Revenue Growth41
Profit Growth40
Capital Growth47
TSR 52w56
Leverage68
Liquidity62
Refinancing48
Combined56
Analyst Opinions59
Pro Holdings93
Opinion Changes50
Market Pulse41

Profile

CountryUK
IndustryCapital Markets
SizeSmall
TypePublic Company
ExchangeLSE
Founded2016
ISINGB00BDGKMY29
Last UpdateApr 2, 2026
Index & Theme
Finance

Description

Biopharma Credit PLC is a healthcare-focused investment company that primarily invests in debt of life sciences companies with the aim of generating attractive risk-adjusted returns. The company operates predominantly through debt instruments and oth…

Similar Stocks

The companies this stock is ranked against.

Compare BioPharma Credit with its peers
International Biotechnology Trust
LSE:IBT
90
CountryUK
IndustryCapital Markets
SizeSmall
Full Stock Analysis →
RTW Biotech Opportunities
LSE:RTW
64
CountryGuernsey
IndustryCapital Markets
SizeSmall
Full Stock Analysis →
Sequoia Economic Infrastructure Income Fund
LSE:SEQI
CountryGuernsey
IndustryCapital Markets
SizeSmall
Full Stock Analysis →
TwentyFour Select Monthly Income Fund
LSE:SMIF
CountryGuernsey
IndustryCapital Markets
SizeSmall
Full Stock Analysis →
TwentyFour Income Fund
LSE:TFIF
CountryGuernsey
IndustryCapital Markets
SizeSmall
Full Stock Analysis →
Smithson Investment Trust
LSE:SSON
CountryUK
IndustryCapital Markets
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →